Blood and Marrow Transplant Clinical Trials Network: progress since the State of the Science Symposium 2007.

Item

http://www.wikidata.org/entity/Q37118840

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Blood and Marrow Transplant Cl ...... of the Science Symposium 2007.

@en

Blood and Marrow Transplant Cl ...... of the Science Symposium 2007.

@nl

type

Item

label

Blood and Marrow Transplant Cl ...... of the Science Symposium 2007.

@en

Blood and Marrow Transplant Cl ...... of the Science Symposium 2007.

@nl

prefLabel

Blood and Marrow Transplant Cl ...... of the Science Symposium 2007.

@en

Blood and Marrow Transplant Cl ...... of the Science Symposium 2007.

@nl

P1476

Blood and Marrow Transplant Cl ...... of the Science Symposium 2007.

@en

P2093

James L M Ferrara

http://www.w3.org/2001/XMLSchema#string

P2860

Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease

Hematopoietic cell transplantation for Crohn's disease; is it time?

High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis.

An aerobic exercise program for patients with haematological malignancies after bone marrow transplantation.

Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysis.

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial.

Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation

Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission.

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study

P304

149-153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1016/J.BBMT.2013.11.006

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258635294

http://www.w3.org/2001/XMLSchema#string

P698

24239651

http://www.w3.org/2001/XMLSchema#string

P932

4957643

http://www.w3.org/2001/XMLSchema#string